CymaBay Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
CymaBay Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2012 to Q4 2023.
  • CymaBay Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending December 31, 2023 was $3.23M, a 10.9% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $3.23M +$318K +10.9% Dec 31, 2023 10-K 2024-02-28
Q3 2023 $2.88M -$202K -6.56% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.85M -$1.17M -38.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.73M -$715K -29.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.91M +$1.19M +69.1% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $3.08M +$1.36M +79% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.03M +$1.58M +109% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.45M +$1M +69.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.72M +$1.51M +731% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.72M +$1.56M +976% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.45M +$1.29M +804% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.45M +$1.29M +804% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $207K +$47K +29.4% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $160K -$1.1M -87.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $160K -$570K -78.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $160K -$962K -85.7% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $160K -$2.12M -93% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $1.26M -$102K -7.48% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $730K -$633K -46.4% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.12M +$142K +14.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $2.28M +$1.65M +260% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $1.36M +$729K +115% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $1.36M +$559K +69.5% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $980K +$226K +30% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $634K -$120K -15.9% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $634K +$413K +187% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $804K +$583K +264% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $754K +$533K +241% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $754K +$13K +1.75% Dec 31, 2016 10-K 2018-03-15
Q3 2016 $221K $0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $221K -$71K -24.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $221K +$63K +39.9% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $741K +$582K +366% Dec 31, 2015 10-K 2017-03-23
Q3 2015 $221K +$62K +39% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $292K -$222K -43.2% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $158K -$45K -22.2% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $159K -$99K -38.4% Dec 31, 2014 10-K 2016-03-29
Q3 2014 $159K +$117K +279% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 $514K Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $203K Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $258K +$216K +514% Dec 31, 2013 10-K 2015-03-23
Q3 2013 $42K Sep 30, 2013 10-Q/A 2013-12-16
Q4 2012 $42K Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.